嘧啶苯芥(合—520)是我国自行设计制造的一种新抗肿瘤药物。经动物实验及临床试用,对白血病有较好的疗效,其次为恶性淋巴瘤,对部分实体瘤也有一定疗效。为了观察嘧啶苯芥对乳腺癌的作用,我科自1976年5月起,对37例乳腺肿物的女性患者应用此药,部分病人因各种原因中途停药,现将能总结疗效的27例,初步总结,报告如下。资料来源自76年5月起,无选择性的 Pyrimidine benzene mustard (HE-520) is a new anti-tumor drug that our country has designed and manufactured. After animal experiments and clinical trials, it has good curative effect on leukemia, followed by malignant lymphoma, and it also has certain curative effect on some solid tumors. In order to observe the effect of pyrimidine benzene mustard on breast cancer, our department has applied this drug to 37 women with breast masses since May of 1976. Some patients have stopped due to various reasons and will be able to summarize the efficacy. 27 Examples, preliminary summary, the report is as follows. Source of data since May 76, non-selective